Skip to search formSkip to main contentSkip to account menu

Redergin

Known as: Redergine 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ergoloid mesylates, USP

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Redergin treatment of hypertensive menopausal women
AIM: To assess a hypotensive effect of redergin (dihydroergotoxin)--agonist of dopaminergic receptors--in monotherapy (4.5-6 mg… 
2000
2000
[Redergin treatment of hypertensive menopausal women].
AIM To assess a hypotensive effect of redergin (dihydroergotoxin)--agonist of dopaminergic receptors--in monotherapy (4.5-6 mg… 
1991
1991
[Intensive therapy in syndromes of disorders of cerebral blood circulation in the bed of the anterior cerebral arteries following the removal of middle basal tumors].
255 patients have been examined in the early postoperative period after the removal of tumors located in diencephalic and sella… 
1985
1985
[Electroclinical characteristics of the effect of redergine on penicillin-induced epilepsy].
1985
1985
[The effect of dihydroergotoxin (Redergin tablets, 4.5 mg) on blood pressure and left ventricular function in patients with essential hypertension].
1983
1983
[Use of redergin in patients with vertebrobasilar syndrome].
1981
1981
Effects of repeated administrations of dihydroergotoxine (Redergine) on the sleep-wakefulness cycle in the cat.
Investigations with dihydroergotoxine methane sulfonate (DHET, the active substance of Redergine) indicate that DHET acts on the… 
1981
1981
Effects of dihydroergotoxine methane sulphonate (Redergine) on sleep in cats deprived of paradoxical sleep.
Dihydroergotoxine methane sulphonate (DHET 1.0 mg/kg i.p.) was administered to cats deprived of paradoxical sleep (PS) for 72 h… 
1979
1979
Effects of dihydroergotoxine (Redergine) on the sleep-wakefulness cycle in the cat.
Investigations with dihydroergotoxine (DHE 1.0; 3.0 and 5.0 mg/kg i.p.) indicate that DHE exerts effect on the sleep-wakefulness… 
1979
1979
Inhibition of platelet aggregation by Redergin (in vitro study).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)